India Emerges as the hub for clinical Research
India is emerging as the most potential destination for the international drug makers. It has been believed from all over the world that India is booming with the clinical trails and researches.
Clinical trial is the research study by pharmaceutical firms and organizations, conducting drug discovery process to find out more efficient treatment for patients regarding different types of specific disease. Though a beginner in the field it forms the promising place for conducting the researches with it’s clinically expertise attitude.
Low cost and better access to research related material is considered to be the main advantage of India. In addition, it is flourishing to the great heights due to its innovations as it not only empathizes on the traditional medicines but also formulating new small and large molecule therapies. India is preferred by the international drug manufacturers for carrying out the clinical traits at the global level as it can methodically carry out in the reasonable cost and time analyzing the various phases in the trails.
Initiatives are being taken by the Indian government to support the clinical trials market in the country. It keeps a watch on the moves and provisions made by the Indian government to rationally analyze the future course of direction of the market. The key factors that boost the country's clinical trials are the patient pool, patient recruitment, cost, time, government regulations, rational property, human resources, infrastructure and ethical issues. Moreover a language is not a problem in India as most of the studies are carried out in the English language. India has the availability of a large patient pool that can be recruited at much shorter time. This is one of biggest advantage of conducting clinical trials in India.
All major pharmaceutical companies and Clinical Research Organizations have already started conducting their clinical trials in India, and with improving infrastructure, industry friendly regulations and trained workforce, the growth is only likely to increase in future. In 2006, Indian clinical trails market grew around 65% in 2006 and it is expected to grow nearly 36% between 2006 and 2011 to register revenues worth $546 million in future. India is growing as a preferred destination for global clinical trials and research, with the market being estimated to reach $1.5 billion by 2010, which may trigger a shortage of around 30,000 to 50,000 clinical research professionals by then. Today, India had just 5000 available trained manpower but with very little or no experience.
There are a lot of trials occurring in fields like diabetes, oncology and lifestyle diseases happening in India but to achieve the goal of becoming a global hub of clinical trials, India will have to overcome challenges like unethical trials, delay in trial approval, inappropriate protection of clinical data, and lack of Good Clinical Practice (GCP) certified sites and investigators.
Thus, by improving on the weekness and empathizing on GCP India can surley acchive its goal of becoming a global hub for clinical research.